Tumor Markers: A Guide to Laboratory Testing
Tumor markers are substances that can be detected in blood, urine, or tissue and may be produced by cancer cells or by the body in response to cancer. They are useful in specific situations, but they are not stand-alone cancer tests. This guide explains how tumor marker testing works, when it is used, and how to read results in context.
Key takeaways
- Tumor markers are substances measured in body fluids or tissue; they can be made by cancer cells or by normal cells responding to cancer or other conditions.
- A single tumor marker result cannot diagnose or rule out cancer; diagnosis generally requires imaging, biopsy, and pathology review.
- Tumor markers are most often used to monitor a known cancer, track response to treatment, or watch for recurrence after treatment.
- Some markers are used for screening in specific high-risk groups, but population-wide screening with tumor markers is not generally recommended because of false positives and false negatives.
- Marker levels can rise for reasons unrelated to cancer, including benign conditions, inflammation, and smoking.
- Results are interpreted as trends over time rather than as isolated numbers, and reference ranges vary by laboratory.
What Tumor Markers Are and Where They Are Found
Tumor markers are biological substances that can be measured in blood, urine, body fluids, or tissue samples. Some are proteins or hormones produced directly by tumor cells, while others are produced by normal cells in response to a tumor or by the body's immune reaction. Because these substances can also be present at low levels in healthy people or in people with non-cancerous conditions, a marker is rarely specific to a single disease.
Commonly measured markers include prostate-specific antigen (PSA), carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), CA-125, CA 19-9, CA 15-3, and human chorionic gonadotropin (hCG). Each marker is associated with certain cancer types, but associations are not exclusive. For example, CA-125 is often linked to ovarian cancer but can also be elevated in endometriosis, pregnancy, and liver disease, which is why it is not used alone to diagnose cancer.
How Tumor Marker Testing Is Used in Practice
Tumor markers are most commonly used after a cancer diagnosis has been established by other means. In that setting, a baseline marker level can be recorded before treatment begins, and later measurements can help show whether therapy is working or whether the disease has returned. For some cancers, such as testicular germ cell tumors, marker levels are part of staging and treatment planning.
In a smaller number of situations, markers are used to help evaluate a person with symptoms or an abnormal imaging finding. For example, a markedly elevated AFP in a person with a liver mass may support a diagnosis of hepatocellular carcinoma, and hCG can be measured when a germ cell tumor is suspected. Even then, the marker result is one piece of evidence among imaging, biopsy, and clinical findings. Screening with tumor markers in average-risk people is generally not recommended because many benign conditions raise marker levels and some cancers do not produce them.
What Results Can and Cannot Show
A tumor marker result is a number that must be compared with the reference range used by the testing laboratory. Laboratories can use different assays, calibrators, and units, so a value that is normal at one lab may fall outside the range at another. A result above the reference range does not automatically mean cancer is present, and a result within the reference range does not rule cancer out. Some tumors do not produce measurable markers at all.
Because of this, clinicians look at the direction and rate of change over time rather than a single value. A rising trend after treatment may prompt further imaging or other tests, while a falling trend may suggest a favorable response. Results are always interpreted with the person's history, physical exam, imaging studies, and pathology reports. Patients should ask which marker is being measured, what the reference range is, and how the result will change the plan of care.
Limitations, Variability, and Safety of Testing
Tumor marker tests are generally performed on a blood sample, which carries minimal risk beyond the usual brief discomfort and small bruise at the needle site. The larger limitation is interpretive. False-positive results can lead to anxiety and unnecessary follow-up procedures, while false-negative results can provide false reassurance. Benign conditions such as infections, inflammation, liver disease, kidney disease, and smoking can affect several markers.
Marker levels can also fluctuate for reasons unrelated to the cancer, and some treatments, including certain medications, can influence results. Because of this variability, guidelines from professional organizations generally advise against using tumor markers as a general screening tool in people without symptoms or known risk factors. When markers are used, they are best ordered and interpreted by a clinician who knows the full clinical picture and can decide whether additional testing is warranted.
Frequently Asked Questions
Can a tumor marker test tell me if I have cancer?
No. A tumor marker test alone cannot diagnose cancer or rule it out. Diagnosis usually requires a combination of medical history, physical examination, imaging, and a biopsy with pathology review. Marker results are one part of that picture.
Why do tumor marker levels go up and down?
Levels can change because of the cancer itself, response to treatment, or unrelated conditions such as infection, inflammation, liver or kidney disease, or smoking. Because of this, clinicians usually interpret trends over multiple tests rather than a single result.
Are tumor markers used for cancer screening?
In average-risk people, tumor markers are generally not recommended for routine screening because they can be elevated in benign conditions and normal in some cancers. A few markers may be used in specific high-risk groups or alongside other tests, as decided by a clinician.
What should I ask my doctor about a tumor marker result?
Ask which marker was measured, what the laboratory's reference range is, whether the result should be compared with previous values, and what, if anything, will change in your care based on the result. Also ask whether additional imaging or testing is needed.
Sources
Ready to get tested? Examine the included markers, read the collection notes, and reserve the panel with the LabTestingCenter partner today.
Order Alpha-Fetoprotein (AFP) Tumor Marker TestReviewed by the LabTestingCenter Editorial Team
Each laboratory panel is reviewed by the LabTestingCenter editorial desk against authoritative reference data.